Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in Classrooms
Abstract
:1. Introduction
2. Materials and Methods
2.1. Design
2.2. Selection of Schools and Participation
2.3. Definition of Different Periods Based on Dominant Virus Variants and Mitigation Measures
2.4. Procedures
2.5. Outcomes
2.6. Statistical Analysis
3. Results
3.1. Infection Status—Changes over Time
3.1.1. CPI—Cumulative Percentage of Students with a SARS-CoV-2 Infection
3.1.2. Mean 7-Day Incidence for Infection with SARS-CoV-2 (M7D-I SARS-CoV-2)
3.1.3. Potential SARS-CoV-2 Infection in School Classes (PI-SARS-CoV-2)
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hale, T.; Webster, S.; Petherick, A.; Phillips, T.; Kira, B. COVID-19: Government Stringency Index: Oxford COVID-19 Goverment Response Tracker. Available online: https://www.bsg.ox.ac.uk/research/research-projects/coronavirus-government-response-tracker (accessed on 12 February 2021).
- Chughtai, A.A.; Seale, H.; MacIntyre, C.R. Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: A global analysis. BMC Res. Notes 2013, 6, 216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, S.-A.; Hwang, D.-C.; Li, H.-Y.; Tsai, C.-F.; Chen, C.-W.; Chen, J.-K. Particle Size-Selective Assessment of Protection of European Standard FFP Respirators and Surgical Masks against Particles-Tested with Human Subjects. J. Healthc. Eng. 2016, 2016, 8572493. [Google Scholar] [CrossRef] [Green Version]
- Yi, Y.; Lagniton, P.N.P.; Ye, S.; Li, E.; Xu, R.-H. COVID-19: What has been learned and to be learned about the novel coronavirus disease. Int. J. Biol. Sci. 2020, 16, 1753–1766. [Google Scholar] [CrossRef] [PubMed]
- Giri, A.; Sapkota, B.; Shrestha, R.; Khatiwada, A.P.; Tiwari, R.; Aryal, M.; Timilsina, M.; Bhujel, B.; Adhikari, M.; Sah, R.; et al. A Narrative Review of Personal Protective Equipment Uses in Coronavirus Disease 2019 and Its Disposable Practices. JMA J. 2021, 4, 86–90. [Google Scholar] [CrossRef] [PubMed]
- Hemmer, C.J.; Hufert, F.; Siewert, S.; Reisinger, E. Protection From COVID-19—The Efficacy of Face Masks. Dtsch. Arztebl. Int. 2021, 118, 59–65. [Google Scholar] [CrossRef]
- Prather, K.A.; Wang, C.C.; Schooley, R.T. Reducing transmission of SARS-CoV-2. Science 2020, 368, 1422–1424. [Google Scholar] [CrossRef]
- World Health Organization. Advice on the Use of Masks in the Context of COVID-19: Interim Guidance; World Health Organization: Geneva, Switzerland, 2020. Available online: https://apps.who.int/iris/handle/10665/332293 (accessed on 10 July 2022).
- World Health Organization; United Nations Children’s Fund. Advice on the Use of Masks for Children in the Community in the Context of COVID-19: Annex to the Advice on the Use of Masks in the Context of COVID-19; World Health Organization: Geneva, Switzerland, 2020. Available online: https://apps.who.int/iris/handle/10665/333919 (accessed on 10 July 2022).
- Alkan, B.; Ozalevli, S.; Akkoyun Sert, O. Maximal exercise outcomes with a face mask: The effects of gender and age differences on cardiorespiratory responses. Ir. J. Med. Sci. 2022, 191, 2231–2237. [Google Scholar] [CrossRef] [PubMed]
- Shaw, K.; Butcher, S.; Ko, J.; Zello, G.A.; Chilibeck, P.D. Wearing of Cloth or Disposable Surgical Face Masks has no Effect on Vigorous Exercise Performance in Healthy Individuals. Int. J. Environ. Res. Public Health 2020, 17, 8110. [Google Scholar] [CrossRef]
- Hopkins, S.R.; Dominelli, P.B.; Davis, C.K.; Guenette, J.A.; Luks, A.M.; Molgat-Seon, Y.; Sá, R.C.; Sheel, A.W.; Swenson, E.R.; Stickland, M.K. Face Masks and the Cardiorespiratory Response to Physical Activity in Health and Disease. Ann. Am. Thorac. Soc. 2021, 18, 399–407. [Google Scholar] [CrossRef]
- Schwarz, S.; Jenetzky, E.; Krafft, H.; Maurer, T.; Martin, D. Coronakinderstudien “Co-Ki”: Erste Ergebnisse eines deutschlandweiten Registers zur Mund-Nasen-Bedeckung (Maske) bei Kindern. Mon. Kinderheilkd 2021, 169, 353–365. [Google Scholar] [CrossRef]
- Imran, N.; Zeshan, M.; Pervaiz, Z. Mental health considerations for children & adolescents in COVID-19 Pandemic. Pak. J. Med. Sci. 2020, 36, S67–S72. [Google Scholar] [CrossRef]
- Schwartz, K.D.; Exner-Cortens, D.; McMorris, C.A.; Makarenko, E.; Arnold, P.; van Bavel, M.; Williams, S.; Canfield, R. COVID-19 and Student Well-Being: Stress and Mental Health during Return-to-School. Can. J. Sch. Psychol. 2021, 36, 166–185. [Google Scholar] [CrossRef] [PubMed]
- Esposito, S.; Principi, N. To mask or not to mask children to overcome COVID-19. Eur. J. Pediatr. 2020, 179, 1267–1270. [Google Scholar] [CrossRef]
- Ayran, G.; Köse, S.; Sarıalioğlu, A.; Çelebioğlu, A. Hand hygiene and mask-wearing behaviors and the related factors during the COVID 19 pandemic: A cross-sectional study with secondary school students in Turkey. J. Pediatr. Nurs. 2022, 62, 98–105. [Google Scholar] [CrossRef]
- Betsch, C.; Korn, L.; Felgendreff, L.; Eitze, S.; Thaiss, H. School opening during the SARS-CoV-2 pandemic: Public acceptance of wearing fabric masks in class. Public Health Pract. 2021, 2, 100115. [Google Scholar] [CrossRef]
- Republic of Austria. RIS—Legal Information System of the Federal Government—Austria—Federal Law Gazette and Decrees: Decree of the Federal Ministry of Education, Science and Research GZ 2021-0.559.836. Federal Law Gazette. Available online: https://www.ris.bka.gv.at/Bgbl-Auth/ (accessed on 7 July 2022).
- Republic of Austria. RIS—Legal Information System of the Federal Government—Austria—Federal Law Gazette and Decrees: Decree of the Federal Ministry of Education, Science and Research GZ 2021-0.707.022. Federal Law Gazette. Available online: https://www.bmbwf.gv.at/ (accessed on 7 July 2022).
- Republic of Austria. RIS—Legal Information System of the Federal Government—Austria—Federal Law Gazette and Decrees: Decree of the Federal Ministry of Education, Science and Research GZ 2021-0.796.507. Federal Law Gazette. Available online: https://www.bmbwf.gv.at/ (accessed on 7 July 2022).
- Republic of Austria. RIS—Legal Information System of the Federal Government—Austria—Federal Law Gazette and Decrees: Decree of the Federal Ministry of Education, Science and Research GZ 2022-0.139.182. Federal Law Gazette. Available online: https://www.bmbwf.gv.at/ (accessed on 7 July 2022).
- World Health Organization. SARS-CoV-2 Variant of Concern. Available online: https://www.who.int/activities/tracking-SARS-CoV-2-variants (accessed on 30 June 2022).
- Austrian Agency for Health and Food Safety. SARS-CoV-2 Variants in Austria. Available online: https://www.ages.at/mensch/krankheit/krankheitserreger-von-a-bis-z/coronavirus#c12422 (accessed on 29 June 2022).
- Yamasoba, D.; Kimura, I.; Nasser, H.; Morioka, Y.; Nao, N.; Ito, J.; Uriu, K.; Tsuda, M.; Zahradnik, J.; Shirakawa, K.; et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell 2022, 185, 2103–2115.e19. [Google Scholar] [CrossRef]
- Ito, K.; Piantham, C.; Nishiura, H. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark. J. Med. Virol. 2022, 94, 2265–2268. [Google Scholar] [CrossRef]
- Svensson, A. A note on generation times in epidemic models. Math. Biosci. 2007, 208, 300–311. [Google Scholar] [CrossRef]
- Zhang, M.; Xiao, J.; Deng, A.; Zhang, Y.; Zhuang, Y.; Hu, T.; Li, J.; Tu, H.; Li, B.; Zhou, Y.; et al. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2—Guangdong Province, China, May–June 2021. China CDC Wkly 2021, 3, 584–586. [Google Scholar] [CrossRef]
- Hart, W.S.; Miller, E.; Andrews, N.J.; Waight, P.; Maini, P.K.; Funk, S.; Thompson, R.N. Generation time of the alpha and delta SARS-CoV-2 variants: An epidemiological analysis. Lancet Infect. Dis. 2022, 22, 603–610. [Google Scholar] [CrossRef]
- Ito, K.; Piantham, C.; Nishiura, H. Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark. MBE 2022, 19, 9005–9017. [Google Scholar] [CrossRef]
- Manica, M.; de Bellis, A.; Guzzetta, G.; Mancuso, P.; Vicentini, M.; Venturelli, F.; Bisaccia, E.; Litvinova, M.; Poletti, P.; Marziano, V.; et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission. Lancet Reg. Health-Europe 2022, 19, 100446. [Google Scholar] [CrossRef]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Routledge: New York, NY, USA, 1988; ISBN 0805802835. [Google Scholar]
- Howard, J.; Huang, A.; Li, Z.; Tufekci, Z.; Zdimal, V.; van der Westhuizen, H.-M.; von Delft, A.; Price, A.; Fridman, L.; Tang, L.-H.; et al. An evidence review of face masks against COVID-19. Proc. Natl. Acad. Sci. USA 2021, 118, e2014564118. [Google Scholar] [CrossRef]
- Cheng, Y.; Ma, N.; Witt, C.; Rapp, S.; Wild, P.S.; Andreae, M.O.; Pöschl, U.; Su, H. Face masks effectively limit the probability of SARS-CoV-2 transmission. Science 2021, 372, 1439–1443. [Google Scholar] [CrossRef]
- Park, S.-R.; Han, J.; Yeon, Y.M.; Kang, N.Y.; Kim, E.; Suh, B.-F. Long-term effects of face masks on skin characteristics during the COVID-19 pandemic. Skin Res. Technol. 2022, 28, 153–161. [Google Scholar] [CrossRef]
- Eberhart, M.; Orthaber, S.; Kerbl, R. The impact of face masks on children-A mini review. Acta Paediatr. 2021, 110, 1778–1783. [Google Scholar] [CrossRef]
- Gama, R.; Castro, M.E.; van Lith-Bijl, J.T.; Desuter, G. Does the wearing of masks change voice and speech parameters? Eur. Arch. Otorhinolaryngol. 2022, 279, 1701–1708. [Google Scholar] [CrossRef]
- Kisielinski, K.; Giboni, P.; Prescher, A.; Klosterhalfen, B.; Graessel, D.; Funken, S.; Kempski, O.; Hirsch, O. Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards? Int. J. Environ. Res. Public Health 2021, 18, 4344. [Google Scholar] [CrossRef]
- Christensen, P.A.; Olsen, R.J.; Long, S.W.; Snehal, R.; Davis, J.J.; Ojeda Saavedra, M.; Reppond, K.; Shyer, M.N.; Cambric, J.; Gadd, R.; et al. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas. Am. J. Pathol. 2022, 192, 642–652. [Google Scholar] [CrossRef]
- Butt, A.A.; Dargham, S.R.; Loka, S.; Shaik, R.M.; Chemaitelly, H.; Tang, P.; Hasan, M.R.; Coyle, P.V.; Yassine, H.M.; Al-Khatib, H.A.; et al. COVID-19 Disease Severity in Children Infected with the Omicron Variant. Clin. Infect. Dis. 2022, 75, e361–e367. [Google Scholar] [CrossRef] [PubMed]
- Schlegtendal, A.; Eitner, L.; Falkenstein, M.; Hoffmann, A.; Lücke, T.; Sinningen, K.; Brinkmann, F. To Mask or Not to Mask-Evaluation of Cognitive Performance in Children Wearing Face Masks during School Lessons (MasKids). Children 2022, 9, 95. [Google Scholar] [CrossRef]
- Kerbl, R. COVID-19: Masken für Kinder? Eine Einschätzung von UNICEF und WHO. Mon. Kinderheilkd 2021, 169, 97–98. [Google Scholar] [CrossRef]
- Srinivasa-Rao, A.S.R.; Krantz, S.G. Well-Designed Studies are Needed to Assess Adverse Effects on Healthy Lung Function after Long-Term Face Masks Usage. MIC 2021, 1, e1222. [Google Scholar] [CrossRef]
Variable | Time Period | All (n = 614) | p Value | φ | OR (95% CI) | |
---|---|---|---|---|---|---|
GB (n = 419) | SF (n = 185) | |||||
CU% SARS-CoV-2, …, No. [%] | …September 2021 (P1) | 1 (0.2%) | 2 (1.0%) | 0.24 | 0.05 | 4.33 (0.39 to 48.06) |
…October 2021 (P1) | 5 (1.2%) | 5 (2.6%) | 0.30 | 0.05 | 2.17 (0.62 to 7.62) | |
…November 2021 (P2) | 26 (6.2%) | 29 (14.9%) | <0.001 | 0.14 | 2.64 (1.51 to 4.62) | |
…December 2021 (P2) | 38 (9.1%) | 32 (16.4%) | 0.008 | 0.11 | 1.97 (1.19 to 3.26) | |
…January 2022 (P3) | 81 (19.3%) | 85 (43.6%) | <0.001 | 0.25 | 3.22 (2.22 to 4.68) | |
…February 2022 (P3) | 149 (35.6%) | 115 (59.0%) | <0.001 | 0.22 | 2.61 (1.84 to 3.69) | |
…March 2022 (P4) | 215 (51.3%) | 120 (61.5%) | 0.018 | 0.10 | 1.52 (1.07 to 2.15) | |
…April 2022 (P4) | 229 (54.7%) | 124 (63.6%) | 0.037 | 0.09 | 1.45 (1.02 to 2.06) | |
M.S. (n = 289) | ||||||
GB (n = 190) | SF (n = 99) | |||||
CU% SARS-CoV-2, …, No. [%] | …September 2021 (P1) | 0 (0.0%) | 1 (1.0%) | 0.34 | 0.08 | INC |
…October 2021 (P1) | 2 (1.1%) | 2 (2.0%) | 0.61 | 0.04 | 1.94 (0.27 to 13.97) | |
…November 2021 (P2) | 9 (4.7%) | 15 (15.2%) | 0.002 | 0.18 | 3.59 (1.51 to 8.54) | |
…December 2021 (P2) | 15 (7.9%) | 18 (18.2%) | 0.009 | 0.15 | 2.59 (1.24 to 5.40) | |
…January 2022 (P3) | 33 (17.4%) | 40 (40.4%) | <0.001 | 0.25 | 3.23 (1.86 to 5.59) | |
…February 2022 (P3) | 70 (36.8%) | 60 (60.6%) | <0.001 | 0.23 | 2.64 (1.60 to 4.35) | |
…March 2022 (P4) | 101 (53.2%) | 64 (64.6%) | 0.06 | 0.11 | 1.61 (0.98 to 2.66) | |
…April 2022 (P4) | 107 (56.3%) | 66 (66.7%) | 0.09 | 0.10 | 1.55 (0.94 to 2.58) | |
H.S. (n = 325) | ||||||
GB (n = 229) | SF (n = 96) | |||||
CU% SARS-CoV-2, …, No. [%] | …September 2021 (P1) | 1 (0.4%) | 1 (1.0%) | 0.50 | 0.04 | 2.40 (0.15 to 38.77) |
…October 2021 (P1) | 3 (1.3%) | 3 (3.1%) | 0.37 | 0.06 | 2.43 (0.48 to 12.26) | |
…November 2021 (P2) | 17 (7.4%) | 14 (14.6%) | 0.045 | 0.11 | 2.13 (1.00 to 4.52) | |
…December 2021 (P2) | 23 (10.0%) | 14 (14.6%) | 0.24 | 0.07 | 1.53 (0.75 to 3.12) | |
…January 2022 (P3) | 48 (21.0%) | 45 (46.9%) | <0.001 | 0.26 | 3.32 (1.99 to 5.55) | |
…February 2022 (P3) | 79 (34.5%) | 55 (57.3%) | <0.001 | 0.21 | 2.55 (1.56 to 4.15) | |
…March 2022 (P4) | 114 (49.8%) | 56 (58.3%) | 0.16 | 0.08 | 1.41 (0.87 to 2.29) | |
…April 2022 (P4) | 122 (53.3%) | 58 (60.4%) | 0.24 | 0.07 | 1.34 (0.83 to 2.17) |
Variable | Time Period | Mean AGES 7-day I (5 to 14) | M.S. (n = 289) | t a | p Value | p-lvl | M.D. | 95% CI | ||
---|---|---|---|---|---|---|---|---|---|---|
GB (n = 190) | SF (n = 99) | |||||||||
Lo | Up | |||||||||
Mean 7-day I (CR) | P1 | 370.02 | 118.85 ± 202.19 | 251.62 ± 251.08 | −4.549 | <0.001 | *** | −132.77 | −190.40 | −75.15 |
P2 | 1521.82 | 783.81 ± 732.41 | 1903.99 ± 564.43 | −14.412 | <0.001 | *** | −1120.17 | −1273.26 | −967.08 | |
P3 | 2797.19 | 3593.86 ± 1502.88 | 5319.90 ± 653.95 | −13.558 | <0.001 | *** | −1726.04 | −1976.64 | −1475.44 | |
P4 | 2361.77 | 2372.95 ± 1155.04 | 906.38 ± 870.70 | 12.105 | <0.001 | *** | 1466.57 | 1227.96 | 1705.19 | |
Mean AGES 7-day I (15 to 24) | H.S. (n = 325) | |||||||||
GB (n = 229) | SF (n = 96) | |||||||||
Mean 7-day I (CR) | P1 | 268.88 | 196.43 ± 335.04 | 404.16 ± 507.97 | −3.685 | <0.001 | *** | −207.73 | −319.25 | −96.21 |
P2 | 962.70 | 1030.43 ± 768.68 | 1370.41 ± 1145.24 | −2.668 | <0.001 | *** | −339.98 | −592.08 | −87.88 | |
P3 | 2497.02 | 3141.79 ± 994.91 | 5324.14 ± 1282.66 | −14.897 | <0.001 | *** | −2182.35 | −2471.88 | −1892.82 | |
P4 | 2185.20 | 2488.14 ± 1203.69 | 602.6 ± 582.11 | 18.992 | <0.001 | *** | 1885.55 | 1690.21 | 2080.88 |
Time Period | School Grade | Category | HTPPI GT 2D | HTPPI GT 4D | HTPPI GT 6D | HTPPI GT 8D |
---|---|---|---|---|---|---|
OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |||
P1 | All (n = 614) | GB (n = 419) | INC | INC | INC | INC |
SF (n = 185) | ||||||
M.S. (n = 289) | GB (n = 190) | INC | INC | INC | INC | |
SF (n = 99) | ||||||
H.S. (n = 325) | GB (n = 229) | INC | INC | INC | INC | |
SF (n = 96) | ||||||
P2 | All (n = 614) | GB (n = 419) | 5.16 (1.32 to 20.19) | 2.78 (1.08 to 7.15) | 2.92 (1.26 to 6.79) | 2.87 (1.28 to 6.44) |
SF (n = 185) | ||||||
M.S. (n = 289) | GB (n = 190) | INC | 12.19 (1.45 to 02.76) | 4.02 (0.98 to 16.44) | 4.74 (1.20 to 8.76) | |
SF (n = 99) | ||||||
H.S. (n = 325) | GB (n = 229) | 1.60 (0.26 to 9.75) | 1.38 (0.39 to 4.82) | 2.49 (0.85 to 7.32) | 2.17 (0.77 to 6.17) | |
SF (n = 96) | ||||||
P3 | All (n = 614) | GB (n = 419) | 4.02 (2.38 to 6.81) | 4.03 (2.56 to 6.31) | 3.78 (2.45 to 5.83) | 3.30 (2.18 to 4.99) |
SF (n = 185) | ||||||
M.S. (n = 289) | GB (n = 190) | 4.24 (2.00 to 8.99) | 3.77 (1.96 to 7.24) | 3.50 (1.88 to 6.53) | 3.01 (1.64 to 5.51) | |
SF (n = 99) | ||||||
H.S. (n = 325) | GB (n = 229) | 3.79 (1.81 to 7.93) | 4.29 (2.29 to 8.01) | 4.08 (2.23 to 7.43) | 3.64 (2.06 to 6.42) | |
SF (n = 96) | ||||||
P4 | All (n = 614) | GB (n = 419) | INC | 0.05 (0.01 to 0.39) | 0.11 (0.04 to 0.37) | 0.14 (0.05 to 0.38) |
SF (n = 185) | ||||||
M.S. (n = 289) | GB (n = 190) | INC | 0.10 (0.01 to 0.79) | 0.15 (0.04 to 0.65) | 0.21 (0.06 to 0.70) | |
SF (n = 99) | ||||||
H.S. (n = 325) | GB (n = 229) | INC | 0.10 (0.01 to 0.79) | 0.08 (0.01 to 0.56) | 0.07 (0.01 to 0.50) | |
SF (n = 96) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jarnig, G.; Kerbl, R.; van Poppel, M.N.M. Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in Classrooms. Int. J. Environ. Res. Public Health 2022, 19, 13511. https://doi.org/10.3390/ijerph192013511
Jarnig G, Kerbl R, van Poppel MNM. Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in Classrooms. International Journal of Environmental Research and Public Health. 2022; 19(20):13511. https://doi.org/10.3390/ijerph192013511
Chicago/Turabian StyleJarnig, Gerald, Reinhold Kerbl, and Mireille N. M. van Poppel. 2022. "Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in Classrooms" International Journal of Environmental Research and Public Health 19, no. 20: 13511. https://doi.org/10.3390/ijerph192013511
APA StyleJarnig, G., Kerbl, R., & van Poppel, M. N. M. (2022). Effects of Wearing FFP2 Masks on SARS-CoV-2 Infection Rates in Classrooms. International Journal of Environmental Research and Public Health, 19(20), 13511. https://doi.org/10.3390/ijerph192013511